Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Milnacipran on Pain Processing in Fibromyalgia
NCT00793520Phase 3Terminated
- Sponsor
- Forest Laboratories
- Start
- Nov 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of milnacipran in fibromyalgia (FM), sponsored by Forest Laboratories. Started Nov 2008; status: terminated.
02
Drugs
milnacipran
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00793520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00793520.